MedTrace Logo

PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.

NCT03340272 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-03-18

No results posted yet for this study

Summary

The general aim of the study is to describe the use of elective pelvic node irradiation (ENI) in Italy, in patients with intermediate/high/very high-risk prostate cancer patients submitted to adjuvant or radical Radiation Therapy (RT) with or without concomitant Androgen Deprivation hormone Therapy (ADT).

The study aims at the definition of survival, toxicity and QoL data in a representative sample of intermediate, high and very high risk prostate cancer patients consecutively recruited in Italian Radiation Oncology Center over two years.

Conditions

  • Intermediate Risk Prostate Cancer
  • High Risk Prostate Cancer

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    lead OTHER

Principal Investigators

  • Michela Buglione, Prof · University and Spedali Civili - Brescia

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2020-02-21
Completion
2023-02-21

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340272 on ClinicalTrials.gov